Read article—Features a study by Marcus Shaker, a professor of pediatrics and medicine, that finds routine screening for alpha-gal syndrome—a life-threatening allergy to red meat and other mammal products—in asymptomatic patients is generally not cost-effective. “The central issue is that the test may be sensitive but not always very specific, and a nonspecific test can generate worry and harm without adding benefit,” Shaker said.

Read article—Outlines research by Ilana Cass, professor of obstetrics and gynecology, and PhD candidate Elizabeth Anderson that shows an association between declining human papillomavirus vaccination (HPV) rates and the release of the COVID-19 vaccine.

Read article—Daniel R Lucey, MD a clinical professor of medicine at Geisel School of Medicine was quoted in an article on a paper published recently on Chikungunya virus infection in late pregnancy and potential harm by the virus on babies.

Read article—Features the results of a clinical trial led by Shelby Sullivan, professor of medicine, reporting that a routine outpatient procedure can prevent weight rebound for patients coming off of GLP-1 drugs.

Read article—Features Shelby Sullivan, a professor of medicine, discussing initial results of a clinical trial she’s leading that showing a routine outpatient procedure can prevent weight rebound for patients transitioning off of GLP-1 drugs. “If validated in the full trial, this procedure could fundamentally change how we think about GLP-1 therapy,” Sullivan said. (Similar coverage in Welltica, HealthDay, and DocWire News.)

Read article—Karen Fortuna, assistant professor of community and family medicine, and Vedan Taplivana ’26, created an app for tracking Alzheimer’s progression. The app, called RealVision, tracks how users interact with their phones, noting such changes as disoriented eye movement, difficulty with typing, or needing more time to respond to prompts. “Some of these patterns are quite nuanced and may not be easily noticeable to the human eye in real time,” Fortuna said. “That’s where computational approaches can help by detecting patterns across many small signals over time.”

Red article—Features a clinical trial led by Shelby Sullivan, a professor of medicine, reporting that an outpatient procedure used to treat type 2 diabetes can help prevent people from regaining weight after discontinuing  GLP-1 drugs. “Finding a treatment that allows patients to stop these medications without weight regain or loss of metabolic benefit is a huge ​unmet need,” Sullivan said. (Similar coverage in New Hampshire Union Leader and HealthDay.)

Read article—Quotes Steven Woloshin, MED ’96, a professor of health policy and clinical practice and co-director of The Dartmouth Institute’s Center for Medicine and Media, who cautions patients to question telehealth providers. “It seems like you’re getting a bargain, but you’re taking your eye off the prize, which is: Do I have something that should be treated with a pill? Will this pill help me? Will the benefits outweigh the harms?” Woloshin said.

Read article—Comments by Paul Holtzheimer, a professor of psychiatry and surgery, underscore ongoing skepticism around psychedelic therapies amid growing advocacy and political momentum. “I don’t think we have the randomized control trial data yet on any of these agents to really say the data is there,” Holtzheimer said.